rBCGΔureC::Hly (VPM1002) SARS-CoV-2 clinical Trials 治験情報 https://t.co/uvdJ5EhubX https://t.co/uL4C3KoS5l https://t.co/kVIxW5UVRV https://t.co/SmO8DxelST 参考資料 https://t.co/FhMlKmL3ZO https://t.co/7XAB3CGBME https://t.co/C8pYpNZDNr https://t.co/Ez4fiRDFmO
RT @influenzer3: 2) BCGのurease Cの遺伝子をlisteriolysinの遺伝子に置き換えたもの。 The Recombinant Bacille Calmette–Guérin Vaccine VPM1002: Ready for Clinical…
RT @influenzer3: 2) BCGのurease Cの遺伝子をlisteriolysinの遺伝子に置き換えたもの。 The Recombinant Bacille Calmette–Guérin Vaccine VPM1002: Ready for Clinical…
RT @influenzer3: 2) BCGのurease Cの遺伝子をlisteriolysinの遺伝子に置き換えたもの。 The Recombinant Bacille Calmette–Guérin Vaccine VPM1002: Ready for Clinical…